Moderate

Abnormal cervical screening & colposcopy

Cervical screening · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Primary high-risk HPV testing with reflex cytology triages women for colposcopy, where cervical intraepithelial neoplasia is diagnosed and treated to prevent progression to cervical cancer.

Red flags

  • Clinically suspicious or friable cervix
  • Abnormal bleeding (postcoital, intermenstrual, postmenopausal)
  • Colposcopic features of invasion
  • Glandular abnormalities (higher cancer risk)
  • Persistent high-grade disease

Assessment

Differential diagnosis

  • Transient HPV infection
  • Low-grade (CIN1) changes
  • High-grade (CIN2/3) changes
  • Glandular abnormality (CGIN)
  • Invasive cervical cancer
  • Benign reactive changes

Investigations

  • Primary high-risk HPV test on the screening sample
  • Reflex cytology if HPV positive
  • Colposcopy with acetic acid and iodine staining
  • Directed punch biopsy of abnormal areas
  • Test of cure (HPV) after treatment

Management

  • Screen with high-risk HPV testing as the primary test
  • If HPV negative, return to routine recall
  • If HPV positive, examine cytology: refer to colposcopy for abnormal cytology
  • If HPV positive with normal cytology, repeat HPV testing at 12 months and refer if persistently positive
  • At colposcopy, assess the transformation zone and take directed biopsies
  • Treat high-grade disease (CIN2/3) usually by large loop excision of the transformation zone
  • Manage low-grade changes conservatively with surveillance in many cases
  • Arrange HPV-based test of cure around 6 months after treatment
  • Refer any suspicion of invasion urgently for staging and oncology input

Drugs & doses

Local anaesthetic (e.g. lidocaine with adrenaline) for excisional treatment
No routine systemic drug therapy
HPV vaccination for prevention in eligible individuals

Disposition

Screening in primary care; refer HPV-positive abnormal cytology to colposcopy; urgent two-week-wait referral for clinically suspicious cervix or suspected invasion.

Complications & pitfalls

  • Progression to cervical cancer if untreated
  • Preterm birth risk after excisional treatment
  • Bleeding or infection after treatment
  • Cervical stenosis
  • Anxiety and non-attendance

Exam pearls

  • Primary HPV testing is more sensitive than cytology alone
  • Most low-grade changes regress, so avoid overtreatment
  • Excisional treatment, especially repeated or deep, raises later preterm birth risk
  • A visibly abnormal cervix needs urgent referral regardless of screening result

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.